LaTonya J. Hickson

EBioMedicine · 2019

⊕ Open access · CC-BY

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

▲ 1,359

Nature Reviews Nephrology · 2022

⊕ Open access · OA

Cellular senescence: the good, the bad and the unknown

▲ 1,156

Nature Communications · 2022

⊕ Open access · CC-BY

A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues

▲ 1,027

Aging Cell · 2019

⊕ Open access · CC-BY

Targeting senescent cells alleviates obesity‐induced metabolic dysfunction

▲ 683

Frontiers in Cell and Developmental Biology · 2020

⊕ Open access · CC-BY

Human Obesity Induces Dysfunction and Early Senescence in Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells

▲ 174

Journal of the American Society of Nephrology · 2021

⊕ Preprint · OA

Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy

▲ 107

EBioMedicine · 2020

⊕ Open access · CC-BY

Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456

▲ 59

bioRxiv (Cold Spring Harbor Laboratory) · 2021

⊕ Preprint · OA

A New Gene Set Identifies Senescent Cells and Predicts Senescence-Associated Pathways Across Tissues

▲ 59

EBioMedicine · 2026

⊕ Open access · CC-BY

Senolytics, dasatanib plus quercetin, reduce kidney inflammation, senescent cell abundance, and injury while restoring geroprotective factors in murine diabetic kidney disease

▲ 9

Kidney International · 2026

⊕ Preprint · OA

Targeting cellular senescence in diabetic kidney disease: potential of regenerative, cell-based therapies and other senotherapeutic approaches

▲ 6